Pemphigus Foliaceus in Dogs — Management Guide

Practical, evidence-based management of canine pemphigus foliaceus: diagnosis, prednisone + azathioprine therapy, monitoring, and long-term care to maintain quality of life.

Quick Overview

• What it is: Pemphigus foliaceus (PF) is the most common autoimmune skin disease in dogs. The immune system attacks proteins that glue skin cells together, producing pustules, erosions, and crusts.
• Who’s at risk: Any dog can develop PF, but it is more commonly diagnosed in certain breeds (see below) and typically appears in middle-aged dogs.
• Prognosis: Variable. Many dogs respond well to immunosuppressive therapy and can achieve remission or long-term control. Some patients require life-long medication; a minority are refractory and need advanced therapy.

Pathophysiology (Explained Simply)

Pemphigus foliaceus is an antibody-mediated (autoimmune) disease. The dog’s immune system mistakenly produces antibodies directed at proteins that keep keratinocytes (skin cells) attached in the superficial layers of the epidermis. This causes keratinocytes to separate (acantholysis), forming superficial pustules that quickly rupture to leave erosions and yellow crusts. Because the process is limited to more superficial epidermal layers, PF generally does not produce full-thickness skin loss, but the secondary bacterial infection and fluid/protein loss can be significant.

Breed-Specific Risk Factors and Prevalence

PF is reported worldwide and can affect any breed. Some breeds appear predisposed: Akitas, Akita crosses, Chows, Bulldogs, and certain terriers have been over-represented in case series. Middle-aged to older dogs are most commonly affected. Exact prevalence is low (pemphigus diseases are uncommon overall), and breed predisposition varies by geographic population.

Typical Clinical Signs and Stages

Common clinical features:

• Superficial pustules (often not seen because they are fragile)
• Erosions and thick yellow crusts
• Lesions commonly begin on the face (muzzle, eyelids, pinnae), ear margins, footpads, and nail folds
• Nasal planum and footpad crusting and fissuring is characteristic in many cases
• Pruritus is variable (some dogs itch, others are only mildly uncomfortable)
• Secondary bacterial infection may produce malodorous discharge
• Systemic signs (fever, lethargy, anorexia) are uncommon but can occur with severe disease or widespread infection

• Mild: localized crusting/pustules (face, ears, paws); minimal systemic signs
• Moderate: multifocal lesions, more extensive crusting, intermittent systemic signs
• Severe: widespread lesions, secondary infection, weight loss, risk of sepsis in extreme cases

Diagnostic Approach

Treatment Options

Treatment goals: control immune-mediated skin injury, treat secondary infection, minimize medication side effects, and eventually reach the lowest effective maintenance dose.

General principles

• Start effective immunosuppression promptly to reduce new pustule formation and promote healing.
• Treat secondary bacterial infections with culture-directed antibiotics when present.
• Monitor closely for drug adverse effects and for relapse during tapering.

1) Glucocorticoids (prednisone/prednisolone) - Mechanism: rapid anti-inflammatory and immunosuppressive effects. - Typical induction dose: prednisone or prednisolone 2–4 mg/kg/day (often started at ~2 mg/kg/day and adjusted based on severity). Some clinicians dose based on body surface area (mg/m2) — a familiar reference dose is 60–90 mg/m2/day. - Maintenance: taper every 2–4 weeks to the lowest effective dose; many dogs can be moved to every-other-day dosing as they improve. - Considerations: steroids often produce rapid clinical improvement but have significant side effects when used long-term.

2) Azathioprine (steroid-sparing adjunct) - Mechanism: purine antimetabolite that suppresses lymphocyte proliferation. - Typical dosing in dogs: 1–2 mg/kg PO once daily (commonly 2 mg/kg/day) OR 50–100 mg/m2/day. Some clinicians use azathioprine every other day to reduce side effects (e.g., 2 mg/kg every 48 hours) — but the daily regimen is more common for induction. - Time to effect: may take 2–8 weeks; therefore azathioprine is used alongside prednisone at first. - Efficacy: combined prednisone + azathioprine is a well-established regimen; retrospective studies show many dogs reach remission with this combination (commonly reported remission rates in series range roughly 60–80% with combination therapy), but individual response varies.

Alternative and adjunct immunosuppressives (used when azathioprine contraindicated or ineffective)

• Cyclosporine: 5–10 mg/kg/day (sometimes divided BID). Useful as a steroid-sparing agent.
• Mycophenolate mofetil: 10–20 mg/kg PO every 12 hours. Emerging use for autoimmune skin disease.
• Chlorambucil: alkylating agent used less commonly in dogs (dosing individualized; often used in combination with lower-dose steroids).
• Leflunomide: 2–4 mg/kg/day in some cases.
• Intravenous therapies (IVIG, plasmapheresis): reserved for life-threatening or refractory cases and available at specialty centers.

• Not applicable for generalized PF. Local surgical excision is not a treatment for autoimmune crusting disease.

• Gentle cleansing, antiseborrheic shampoos, topical antimicrobials if localized bacterial overgrowth.
• Keep nasal planum and footpads clean and moisturized; topical emollients (as directed by your vet) can relieve fissures.
• Address secondary infections with culture-directed antibiotics; topical mupirocin/polymyxin preparations can be useful for focal lesions.

Monitoring for Side Effects

Before starting azathioprine or long-term steroids:

• Baseline CBC and chemistry including ALT/AST/ALKP, bilirubin, urea, creatinine, and urinalysis.

• Azathioprine: CBC and ALT every 7–14 days for the first 6–8 weeks, then monthly for 3–6 months, then every 2–3 months once stable. Watch for leukopenia, thrombocytopenia, or elevated liver enzymes—dose reduction or discontinuation may be necessary.
• Prednisone: monitor for clinical signs of Cushing’s (PU/PD, polyphagia, panting), hyperglycemia, elevated liver enzymes and concurrent infections. Check blood glucose if clinical signs of diabetes develop.

• Prednisone: polyuria/polydipsia, polyphagia, weight gain, panting, behavioral changes, increased susceptibility to infection, GI ulceration, steroid hepatopathy.
• Azathioprine: bone marrow suppression (life-threatening if severe), hepatotoxicity, vomiting or anorexia. Rarely pancreatitis.

Long-Term Management and Monitoring

• Goal: reach an extended remission with the lowest effective medication dose or complete drug-free remission in some dogs.
• Typical practice: continue combination therapy through induction until clinical remission (weeks to months), then gradually taper prednisone first and maintain azathioprine for several months after remission (common practice is to continue an adjunct immunosuppressant for 4–6 months beyond clinical remission, although individual protocols vary).
• Regular rechecks: initially every 2–4 weeks while tapering, then every 1–3 months when stable. Routine lab monitoring as above.
• Owners should keep a lesion diary and photos to help detect early relapse.
• Vaccination: live vaccines are generally avoided while on significant immunosuppression; discuss vaccine timing with your vet.

Prognosis and Quality of Life

• Prognosis is guarded to good depending on severity and response to therapy. Many dogs achieve excellent quality of life on medical management.
• Complete cure (drug-free remission) occurs in a proportion of dogs but is not guaranteed; relapses are common when drugs are tapered too quickly.
• Long-term side effects of therapy can affect quality of life (e.g., steroid side effects). The goal is symptom control with minimal medication-related morbidity.

Living With Pemphigus Foliaceus — Practical Daily Tips

• Routine care: gently clean crusted areas with warm saline compresses to soften crusts before bathing; use veterinarian-recommended gentle shampoos.
• Footpads and nose: apply pet-safe emollients for fissured pads and nose; avoid human ointments unless recommended by your vet.
• Diet and weight: monitor caloric intake—steroids increase appetite. Maintain healthy weight with portion control and vet-guided diet adjustments.
• Prevent infections: keep the environment clean; avoid dog parks or kennels during heavy immunosuppression.
• Medication adherence: give medications exactly as prescribed; abrupt cessation of prednisone can cause adrenal insufficiency and disease flare.
• Photography: take regular photos of lesions to document progress or early relapse.

When to See Your Vet Urgently

Contact your veterinarian or emergency clinic immediately if your dog has:

• Sudden onset of lethargy, vomiting, diarrhea, or collapse
• Fever, marked weakness, or signs of sepsis (very sick-looking)
• Worsening skin disease despite treatment or rapid spread of crusts/pustules
• Signs of severe drug reaction: pale gums, bleeding/bruising, difficulty breathing, sudden anorexia
• Marked polyuria/polydipsia, or any seizure-like activity

Key Takeaways

• Pemphigus foliaceus is an autoimmune disease that commonly causes nasal and footpad crusting and superficial pustules.
• Skin biopsy is the diagnostic gold standard; cytology is supportive.
• Prednisone plus azathioprine is a commonly used and effective first-line combination. Prednisone induction ~2–4 mg/kg/day with azathioprine 1–2 mg/kg/day (or 50–100 mg/m2/day) is typical; taper carefully.
• Monitor CBC and liver enzymes closely for azathioprine toxicity and watch for steroid side effects. Regular rechecks and lab work are essential.
• With appropriate therapy and monitoring most dogs can achieve good control and maintain a good quality of life.

• Veterinary Dermatology (Wiley Online Library): https://onlinelibrary.wiley.com/journal/13653164
• PubMed: pemphigus foliaceus in dogs — case series and reviews: https://pubmed.ncbi.nlm.nih.gov/?term=pemphigus+foliaceus+dog
• American College of Veterinary Internal Medicine (ACVIM): https://www.acvim.org
• Muller and Kirk's Small Animal Dermatology (textbook reference)

Frequently Asked Questions